FY2025 · ended Dec 31, 2025 · Revenue $1.88B, -26.6% YoY · Filed Feb 25, 2026
Evolent Health, Inc. (EVH) files with the SEC under industry code 8741, Services-Management Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.9 billion and a net loss of $534.5 million. As of Sep 30, 2026 it held $148.3 million in cash and investments and $973.0 million in total debt.
Revenue (TTM)
$2.34B
+14.1% vs year-ago TTM
Net income (TTM)
$-507.69M
-296.1% vs year-ago TTM
Operating cash flow (TTM)
$64.88M
+279.3% vs year-ago TTM
Free cash flow
$-78.18M
-29.9% vs prior year
EPS (TTM)
$-4.52
-187.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
111.64M
-4.2% vs prior year
Net cash
$-824.79M
as of Sep 30, 2026
Operating margin
-18.5%
FY 2026
Company profile
- Industry
- Services-Management Services (SIC 8741)
- Listed as
- EVH (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Arlington, VA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1628908
Other Services-Management Services companies
- Gartner Inc IT
- Rentokil Initial PLC /FI RTO
- Bryn Inc. MDTK
- Dreamland Ltd TDIC
- Sky Century Investment, Inc. SKYI
- Franklin Covey Co FC
- Kioni Holdings Ltd KNIH
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $1.9B | $2.6B | $2.0B | $1.4B | $924.6M |
| Operating income | -$410.1M | -$40.5M | -$71.2M | $3.6M | -$262.8M |
| Net income | -$534.5M | -$61.6M | -$113.0M | -$19.2M | -$334.2M |
| Diluted EPS | -$5.07 | -$0.81 | -$1.28 | -$0.20 | — |
| Operating cash flow | $38.8M | $18.8M | $142.6M | -$11.6M | -$16.2M |
| Total assets | $1.9B | $2.5B | $2.7B | $1.8B | $1.4B |
| Total liabilities | $1.5B | $1.4B | $1.4B | $957.9M | $752.1M |
| Stockholders' equity | $415.2M | $1.0B | $1.1B | $859.4M | $619.6M |
| Cash and investments | $151.9M | $104.2M | $192.8M | $188.2M | $319.0M |
| Total debt | $989.7M | $713.7M | $644.8M | $476.1M | $359.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
All 857 Evolent Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.